JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Valsalva retinopathy in pregnancy: SD-OCT features during and after Nd:YAG laser hyaloidotomy.

Valsalva retinopathy can present as a sudden, dramatic loss of central vision due to the premacular location of the resultant subhyaloid hemorrhage. Certain vascular conditions predispose to the condition and occasional reports exist of Valsalva retinopathy in pregnancy. The authors describe a case of Valsalva retinopathy in a pregnant patient in terms of the physical features present that led to making the decision to treat by Nd:YAG laser hyaloidotomy as opposed to conservative management. Spectral-domain optical coherence tomography (SD-OCT) was able to demonstrate the physical features of the lesion prior to, immediately after, and weeks after treatment, and showed not only the dispersion of hemorrhage into the vitreous cavity from the subhyaloid space, but also that the subhyaloid cavity dimensions were unchanged despite release of the hemorrhage. SD-OCT visualized the actual hyaloidotomy site and its subsequent closure, which has not previously been reported in the literature.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app